2017 - Immunotherapy: a new standard of care in thoracic malignancies?

2023 - In Vitro Diagnostic (IVD) tests to combat antimicrobial resistance in community-acquired low-respiratory tract infections (CA-LRTI)
2024 - Sleep apnea and its consequences: from animal models to precision medicine
2019 - New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

From ineffective tumor immune response to immunomodulation in lung cancer

F. Pagés (Paris, France)

Assembly Symposium

Slides

Accompanying documents

How to evaluate the immune response in the tissue?

M. Tsao (Toronto, Canada)

Slides

Accompanying documents

Unresolved issues in the use of check-point inhibitors in NSCLC

F. Shepherd (Toronto, Canada)

Slides

Check point inhibitors in advanced non small cell cancer

M. Garassino (Milano, Italy)

Slides

Is there a place for ICI in the context of oncogenic addiction?

J. Cadranel (Paris, France)

Slides

Accompanying documents

Vaccination in non small lung cancer

J.G.J.V. Aerts (Breda, Netherlands)

Slides

Accompanying documents

Check point inhibitors in peri-operative non small cell lung cancer strategy

J. Mazieres (Toulouse, France)

Slides

Accompanying documents

Current clinical trials

T. Berghmans (Brussels, Belgium)

Slides

Accompanying documents

ers-logo-channel

Main ERS website

Membership

ERS Respiratory Channel

Stay up to date

CONTACT ERS

Privacy policy

Cookies policy

Governance and transparency